News-Medical.Net Gene Therapy News
-
Gene therapy protects optic nerve cells and preserves vision in glaucoma mouse models
Jul 24, 2021 | 04:34 amA form of gene therapy protects optic nerve cells and preserves vision in mouse models of glaucoma, according to research supported by NIH's National Eye Institute.
Read more... -
Investigational Oncomagnetic Device shrinks end-stage recurrent glioblastoma
Jul 23, 2021 | 02:32 amHouston Methodist Neurological Institute researchers from the department of neurosurgery shrunk a deadly glioblastoma tumor by more than a third using a helmet generating a noninvasive oscillating magnetic field that the patient wore on his head while administering the therapy in his own home.
Read more... -
Chemical modification in RNA molecules may offer protection against liver disease
Jul 20, 2021 | 02:20 amA chemical modification that occurs in some RNA molecules as they carry genetic instructions from DNA to cells' protein-making machinery may offer protection against non-alcoholic fatty liver, a condition that results from a build-up of fat in the liver and can lead to advanced liver disease, according to a new study by UCLA researchers.
Read more... -
Gene therapy delivered into the brain may be safe, effective in treating rare neurological disorder
Jul 17, 2021 | 03:26 amA new study published in Nature Communications suggests that gene therapy delivered into the brain may be safe and effective in treating aromatic L-amino acid decarboxylase (AADC) deficiency.
Read more... -
Researchers study the role of subnuclear NSrp70 in T cell-mediated adaptive immunity
Jul 15, 2021 | 08:05 amT cells are components of the body’s immune system. The ability of T cells to recognize diverse pathogens and mount a defense against them stems from the way proteins are spliced during their development and maturation.
Read more... -
Yale School of Public Health and Tevogen Bio partner to expand school's regulatory sciences program
Jul 15, 2021 | 02:18 amThe Yale School of Public Health is partnering with Tevogen Bio, a clinical stage biotechnology company, on a major expansion of the school's regulatory sciences program.
Read more... -
Curia to Acquire US-based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics
Jul 14, 2021 | 16:33 pmCuria today announced it has entered into a definitive agreement to acquire LakePharma Inc.
Read more... -
Gene therapy shows promise in children with devastating genetic disorder
Jul 13, 2021 | 03:12 amChildren with a devastating genetic disorder characterized by severe motor disability and developmental delay have experienced sometimes dramatic improvements in a gene therapy trial launched at UCSF Benioff Children's Hospitals.
Read more... -
Novel method of gene therapy promises to transform the treatment of rare genetic disorder
Jul 12, 2021 | 17:05 pmA novel method of gene therapy is helping children born with a rare genetic disorder called AADC deficiency that causes severe physical and developmental disabilities.
Read more... -
Study: Gene editing therapy for early-stage Huntington’s disease may have long-lasting benefits
Jul 8, 2021 | 01:59 amIn a new study on mice, Johns Hopkins Medicine researchers report that using MRI scans to measure blood volume in the brain can serve as a noninvasive way to potentially track the progress of gene editing therapies for early-stage Huntington's disease, a neurodegenerative disorder that attacks brain cells.
Read more...